Connect with us

Technology

Axtria Unveils Analysis of Critical Trends in Pharma Sales and Marketing

Published

on

Axtria analyzed five years of data from more than 140 studies across 70 U.S. brands.Assessed channel effectiveness across varying brands, therapy areas, and markets.Analyzed spending and the effectiveness of promotional channels.

BERKELEY HEIGHTS, N.J., Feb. 14, 2024 /PRNewswire/ — Axtria Inc., a global leader in cloud software and data analytics for the life sciences industry, today released an analysis of pharma sales and marketing organizations that underscores the industry’s dramatic embrace of digital marketing over the last five years entitled, “Unlocking Promotional Success: Insights from 140+ Marketing Mix Studies.”

Axtria reviewed 140 marketing mix (MMx) studies conducted on sales data between January 2018 and December 2022, capturing transformational shifts driven by the Covid pandemic and evolving market conditions. The analysis illustrates how technologies have profoundly impacted the ways in which pharmaceutical companies engage with healthcare physicians, patients, and account-based customers.

“It’s clear that embracing an omnichannel approach and adapting to changing customer preferences by integrating digital platforms into strategies will be important steps for innovative companies to take,” explained Dr. David Wood, Senior Principal of Decision Science at Axtria. “Axtria is happy to share the valuable insights gained from our work with many life sciences companies to optimize and transform their sales and marketing initiatives. Our products and services, such as Axtria MarketingIQ, help our clients turn insights like these into action.”

The four key trends Axtria uncovered among life sciences companies include:

Life sciences companies are spending more on digital media.
Axtria found that spending across digital channels exploded from 6% in 2018 to a high of 30% in 2021. The company said such spending fell slightly to 22% in 2022. Conversely, life sciences spending on conferences dropped dramatically from 10% in 2018 – pre-pandemic – to a low of 1% in 2021. It rose slightly to 2% in 2022.

There is a growing investment in different digital channels.
While spending on online banner ads, display, digital, and alerts held steady from 2018 through 2020 – varying slightly between $4.1 million and $4.4 million per brand– it rapidly increased during the pandemic to $19.2 million in 2021, falling back to $13.3 million in 2022. Similar increases occurred in paid search and social media, rising from less than $1 million in 2020 to $5.5 million and $10.1 million in 2021 and 2022, respectively. The company said email communication remains a valuable tool for reminders and general information.

The effectiveness of digital-channel promotion is improving, with steadily increasing ROI on spending.
Axtria’s analysis showed an ongoing increase in the return on investment that life sciences companies are experiencing from their digital expenditures over the 2018 – 2022 period) – with a demonstrable difference between growth brands and mature brands. The former sometimes showed dramatic growth in the ROI of email and social media. Mature brands showed moderate growth in ROI across all digital channels. Data also showed that healthcare providers are becoming more receptive to digital platforms, engagement on social media is increasing, and digital data offers a high value for data analysis and model building.

Marketing objectives are changing.
Axtria also revealed that a higher emphasis on patient initiation for drug refills is emerging, and companies are emphasizing different channels for patient initiation and refills. These changes will have future implications for budget allocations and expected returns on investment.

“Best-in-class companies will also need to use more marketing analytics to gain customer insights while using product-based solutions to innovate and optimize MMx modeling,” said Wood.

Wood added that a blend of strategic thinking and granular tactical planning will contribute to success and the ability to stay flexible to market changes and adapt to digital transformation. “This kind of agility will help successful companies maximize their returns while improving the customer experience and overall return on investment,” he said.

About Axtria’s Products and Solutions
Axtria is proud to work with 16 of the top 20 pharmaceutical companies. From our roots as a trusted consultant to our status as one of the world’s leading providers of cloud-based pharmaceutical management software, Axtria has been powering the digital transformation of life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.

About Axtria
Axtria is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We focus on improving healthcare outcomes for patients.  We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

PDF – https://mma.prnewswire.com/media/2340168/Axtria_Insights_Infographic_Unlocking_Promotional_Success_ID_0c899c639b72.pdf
Logo – https://mma.prnewswire.com/media/2256316/Axtria_transparent_bg_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/axtria-unveils-analysis-of-critical-trends-in-pharma-sales-and-marketing-302061332.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CEFALY to Demonstrate Its Migraine Treatment Device at the American College of Obstetricians and Gynecologists’ Annual Clinical & Scientific Meeting

Published

on

By

DARIEN, Conn., May 13, 2025 /PRNewswire/ — Medical device maker CEFALY Technology will be conducting live demonstrations of its clinically proven neuromodulation treatment for migraine at Booth 102 at the ACOG Annual Clinical & Scientific Meeting May 16-18, 2025 in Minneapolis, Minnesota.

With more than 60,000 members, the American College of Obstetricians and Gynecologists is the nation’s premier professional membership organization for OB/GYNs. Its Annual Clinical and Scientific Meeting is the country’s largest event dedicated to obstetric and gynecological healthcare.

“Migraine is a complex and often disabling neurological disorder that affects one in five women,” said Jen Trainor-McDermott, CEO of CEFALY Technology. “We look forward to presenting CEFALY’s FDA-cleared migraine treatment device to this esteemed group of clinicians as an effective, safe, and drug-free option for their patients.” 

Migraine predominantly affects women in their childbearing years, yet finding ways to treat migraine safely during pregnancy has been a persistent challenge. Certain commonly used acute and preventative migraine medications are not advised for use during pregnancy, due to the risk of birth defects or other harm to the developing fetus.

In the American Registry of Migraine Research observational study, approximately 20% of women with migraine chose to avoid pregnancy due to migraine. These women cited many reasons for doing so: They believed that their migraine would be worse during pregnancy, they believed the disability caused by migraine would make pregnancy difficult, and they feared migraine medications would negatively affect their child’s development.

Neuromodulation has emerged as a promising non-pharmaceutical treatment option. “While at this time data is limited regarding the true safety of neuromodulation in pregnancy, studies conducted thus far on the available FDA- approved devices for migraine and relevant devices with similar mechanisms of action do not appear to pose a harm to the pregnant patient or the developing fetus,” according to a recent review in Current Pain and Headache Reports

A non-invasive medical device that’s worn on the forehead, CEFALY targets the trigeminal nerve to relieve migraine pain and prevent future attacks. Many women have used CEFALY for migraine relief during pregnancy with no known serious adverse effects. However, the safety and efficacy of CEFALY have not been evaluated in pregnant women. 

CEFALY is currently conducting an online survey registry to help researchers understand the benefits of non-medication options for migraine relief in pregnant women. Michael A. L. Johnson, MD, Medical Affairs Advisor for CEFALY Technology, will be available to discuss the pregnancy registry with attendees, as well as answering questions about the clinical relevance of the CEFALY device. 

CEFALY will offer attendees the chance to try the CEFALY Connected device, so they can experience the sensation of gentle neurostimulation for themselves. CEFALY will also invite clinicians to participate in its online CEFALY Certified education program, which covers the basics of eTNS (external trigeminal nerve stimulation) treatment for migraine.

“CEFALY hopes to build strong relationships with ACOG’s members as we work together to offer women a safe, non-pharmacological treatment for migraine,” said Trainor-McDermott. 

About CEFALY Technology:
CEFALY Technology is the maker of CEFALY, an FDA-cleared, over-the-counter wearable medical device clinically proven to help reduce migraine frequency and relieve migraine pain. CEFALY Technology is a Belgium-based company with its U.S. offices based in Darien, Conn., specializing in electronics for medical applications. CEFALY Technology’s mission is to provide innovative, ever-evolving technology that enables people with migraine to take control of their treatment and live happier, healthier lives.

Learn more about CEFALY by visiting CEFALY.com and following us on Facebook, Twitter, LinkedIn, Instagram and TikTok.

Media Contact:
CEFALY
Jen Trainor-McDermott
CEO
j.trainor@cefaly.com

View original content:https://www.prnewswire.com/news-releases/cefaly-to-demonstrate-its-migraine-treatment-device-at-the-american-college-of-obstetricians-and-gynecologists-annual-clinical–scientific-meeting-302453933.html

SOURCE CEFALY Technology

Continue Reading

Technology

nTop to Host 2025 Computational Design Summit, Spotlighting Engineering Breakthroughs in Aerospace and Manufacturing

Published

on

By

One-day event to explore how AI, simulation, and computational design are accelerating innovation across aerospace, turbomachinery, and advanced manufacturing

LOS ANGELES, May 13, 2025 /PRNewswire-PRWeb/ — nTop, the leader in computational design software for high-performance engineering, is excited to announce the 2025 nTop Computational Design Summit (nCDS), taking place on June 24, 2025, in Los Angeles. The one-day event will bring together industry experts, innovative customers, and nTop executives to explore how computational design, AI, and machine learning are transforming engineering and accelerating product development—delivering faster, smarter, and more adaptable solutions to complex design challenges.

“nCDS is an opportunity to showcase how computational design and AI are changing the way products are developed and brought to market—helping engineers shorten design cycles, improve performance, and meet increasingly complex requirements.” – Bradley Rothenberg, CEO and founder, nTop

“At nTop, we’re committed to pushing the boundaries of what’s possible in engineering,” said Bradley Rothenberg, CEO and founder, nTop. “nCDS is an opportunity to showcase how computational design and AI are changing the way products are developed and brought to market—helping engineers shorten design cycles, improve performance, and meet increasingly complex requirements.”

Engineering organizations are navigating a generational shift, driven by the need for faster development timelines, deeper simulation integration, and AI-enhanced automation. As industries embrace digital transformation, tools that enable rapid iteration, performance optimization, and scalable workflows are becoming essential. nCDS reflects this momentum, bringing together leading voices in high-performance engineering to explore how computational design is reshaping the future of product development.

Featured speakers include:

Carlos Mendez, Staff Opto-Mechanical Engineer, Lockheed MartinMichael Emory, Product Manager, LuminaryMarkus Lempke, Computational Design for AM, Siemens EnergyAndy Kappers, Mechanical Engineer, Siemens EnergyJan Vandenbrande, formerly DARPA, BoeingGeorge Allen, nTop Fellow

Geared towards engineers who want to learn about the tools and methods for applying computational design to their work, nCDS will feature keynote presentations, engineering case studies, partner demonstrations, and hands-on training sessions. Attendees will gain insights into the latest advancements in computational design, including AI-driven engineering workflows, simulation efficiency breakthroughs, and the future of aircraft and turbomachinery design.

Participants will see how leading engineering teams generate validated design variants—complete with geometry and physics results—in hours, rather than weeks. Interactive sessions will demonstrate how computational design enables faster iteration, deeper simulation integration, and better product outcomes across every stage of development.

Event Details:

Date: June 24, 2025

Time: 10:30 AM6:30 PM

Location: Hudson Loft, 1200 S Hope St., Los Angeles, CA 90015

Join engineers from General Atomics, Lockheed Martin, Northrop Grumman, Siemens Energy, and more at nCDS as they explore computational design and the future of AI-driven engineering. Register for the event here: https://www.ntop.com/ncds-2025/.

About nTop

nTop is the computational design platform for high-performance engineering. Built for teams solving the world’s hardest engineering challenges—from hypersonics to heat exchangers—nTop combines GPU-accelerated modeling, in-the-loop simulation, and automation to help engineers generate and evaluate thousands of design variants, including geometry and physics results, in hours, not weeks. Trusted by over 450 teams across aerospace, defense, automotive, and energy, nTop redefines how design is done, turning engineering logic into reusable workflows, enabling rapid exploration of the design space, and shortening product cycles from concept to production. For more information, visit www.ntop.com.

Media Contact

Maya Komadina, nTop, 1 9179839257, press@ntop.com, www.ntop.com 

View original content to download multimedia:https://www.prweb.com/releases/ntop-to-host-2025-computational-design-summit-spotlighting-engineering-breakthroughs-in-aerospace-and-manufacturing-302452085.html

SOURCE nTop

Continue Reading

Technology

Cruisebound Wins “Online Booking Innovation of the Year” in TravelTech Breakthrough Awards

Published

on

By

NEW YORK, May 13, 2025 /PRNewswire/ — Cruisebound, the online cruise agency reinventing how travelers book cruises, was just named Online Booking Innovation of the Year in the TravelTech Breakthrough Awards–a leading global market intelligence platform recognizing excellence in travel and hospitality technology.

As cruising grows in popularity, customers’ expectations are higher than ever.

This year’s awards received thousands of nominations from more than 14 countries. Cruisebound was chosen for its fresh, user-friendly technology and its commitment to reinventing the cruise booking industry. By constantly testing new ideas and fine-tuning the customer experience, Cruisebound has made it easier than ever for travelers to search, compare, book, and earn rewards on cruises from all major lines—whether online or via its mobile app—while still offering access to real human support.

“We’re absolutely thrilled to receive this recognition from TravelTech Breakthrough,” said Pierre-Olivier Lepage, CEO of Cruisebound. “Cruising has long been one of the most complex travel products to book online. Our team set out to change that—to make the process intuitive, stress-free, and still personal. This award is a huge nod to the expertise, creativity, and care we put into everything we build.”

As cruising grows in popularity, thanks in part to a slew of new ship and destination experiences, plus its status as one of the best value-per-dollar products in the travel industry, customers’ expectations are higher than ever. Cruisebound is leading the way and breaking down barriers left by legacy systems. By building a modern cruise booking experience—one that feels as easy as booking a flight or hotel—Cruisebound brings more brand-new customers to the industry every day.

The TravelTech Breakthrough Awards honor the most forward-thinking companies and innovations shaping the future of travel. Their mission is to spotlight user-first design and technologies that drive both impact and growth across the industry.

For more on Cruisebound, visit www.cruisebound.com.

About Cruisebound

Cruisebound, founded in 2022, helps consumers find and compare cruises from every major cruise line to find the best fit for vacation needs. Comprehensive inventory with real-time pricing and instant booking, customer service team available to answer questions, and no booking fees sets Cruisebound apart from competitors. Whether it’s a multigenerational family trip to Mexico with Royal Caribbean, an anniversary celebration in the Mediterranean on Virgin Voyages or a once-in-a-lifetime Alaska adventure with Norwegian Cruise Line, Cruisebound makes it easy to discover and book your perfect cruise. For more information, or to book your next cruise, visit: www.cruisebound.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cruisebound-wins-online-booking-innovation-of-the-year-in-traveltech-breakthrough-awards-302453063.html

SOURCE Cruisebound, Inc.

Continue Reading

Trending